NNIT informs that the company has been requested by Novo Nordisk to explore the potential for a listing on NASDAQ OMX Copenhagen. The aim is to explore the potential for an IPO and to evaluate whether a listing of NNIT would support the continued development and value creation of the company. A decision about the future ownership of NNIT will be made based on the outcome of the evaluation.